Company name: Emerald Health Bioceuticals / Emerald Health Therapeutics (Joint Venture)
Description: Distributor of endocannabinoid-supporting products to Canadian natural health product stores and pharmacies The company’s product line consists of nutritional supplements that use non-cannabis, non-psychoactive plant-based bioactive compounds to support the body’s endocannabinoid system of neurotransmitters that bind to cannabinoid receptors.
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
State: British Columbia
Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Privately Held (no backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: Emerald Health Therapeutics (TSXV: EMH) and Emerald Health Bioceuticals have entered into an agreement to form a joint venture as of November 19, 2018.
Number of active investors:
Profile last updated: 22-Nov-2018
Last known valuation:
Last known valuation date: